Dexamethasone-cyclophosphamide pulse therapy forautoimmune-vesiculobullousdisorders at Victoria hospital, Bangalore

Dermatology Online Journal

Volumn 9, Issue 5, 2003, Pages 10-14

  Sacchidanand, S ^a   Hiremath, N C ^a   Natraj, H V ^a   Revathi, T N ^a   Shobha Rani, R H ^b   Pradeep, Geeta ^b   Tenneti, Vijay ^b  

^a Victoria Hospital   (India)

^b AL AMEEN COLLEGE OF PHARMACY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS HERPETIFORMIS; DRUG EFFICACY; DRUG PULSE THERAPY; FEMALE; FOLLOW UP; HUMAN; HYPERGLYCEMIA; INDIA; MALE; MORTALITY; MUCORMYCOSIS; PEMPHIGOID; PEMPHIGUS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; RECURRENCE RISK; REMISSION; TREATMENT PLANNING; TREATMENT WITHDRAWAL;

EID: 3142582455     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Kar PK, Murthy PS, Rajagopal R, Indian J Dermatol Leprol. 69: 109-111, 2003.
2. Bystryn J. Arch Dermatol. 1984 Jul;120(7):941-51. PubMed
3. Bystryn J, Steinman N. The adjuvant therapy of pemphigus. An update. Arch Dermatol. 1996 Feb;132(2):203-12. PubMed
4. Carson PJ, Hameed A, Ahmed AR. Influence of treatment on the clinical course of pemphigus vulgaris. J Am Acad Dermatol. 1996 Apr;34(4):645-52. PubMed
5. The big shot. Lancet. 1977 Mar 19;1(8012):633-4. PubMed
6. Pasricha JS, Thanzama J, Khan UK. Intermittent high-dose dexamethasone-cyclophosphamide therapy for pemphigus. Br J Dermatol. 1988 Jul;119(1):73-7. PubMed
7. Kaur S, Kanvar AJ. Dexamethasone-cyclophosphamide pulse therapy in pemphigus. Int J Dermatol. 1990 Jun;29(5):371-4. PubMed
8. Toth GG, van de Meer JB, Jonkman MF. Dexamethasone pulse therapy in pemphigus. J Eur Acad Dermatol Venereol. 2002 Nov;16(6):607-11. PubMed